Your browser doesn't support javascript.
loading
Exogenous mitochondrial transfer and endogenous mitochondrial fission facilitate AML resistance to OxPhos inhibition.
Saito, Kaori; Zhang, Qi; Yang, Haeun; Yamatani, Kotoko; Ai, Tomohiko; Ruvolo, Vivian; Baran, Natalia; Cai, Tianyu; Ma, Helen; Jacamo, Rodrigo; Kuruvilla, Vinitha; Imoto, Junichi; Kinjo, Sonoko; Ikeo, Kazuho; Moriya, Kaori; Suzuki, Koya; Miida, Takashi; Kim, Yong-Mi; Vellano, Christopher P; Andreeff, Michael; Marszalek, Joseph R; Tabe, Yoko; Konopleva, Marina.
Afiliação
  • Saito K; Department of Clinical Laboratory Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
  • Zhang Q; Section of Leukemia Biology Research, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Yang H; Department of Clinical Laboratory Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
  • Yamatani K; Department of Clinical Laboratory Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
  • Ai T; Research Fellow of the Japan Society for the Promotion of Science, Tokyo, Japan.
  • Ruvolo V; Department of Clinical Laboratory Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
  • Baran N; Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Cai T; Section of Leukemia Biology Research, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Ma H; Section of Leukemia Biology Research, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Jacamo R; Section of Leukemia Biology Research, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Kuruvilla V; Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Imoto J; Section of Leukemia Biology Research, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Kinjo S; Center for Information Biology, National Institute of Genetics, Shizuoka, Japan.
  • Ikeo K; Center for Information Biology, National Institute of Genetics, Shizuoka, Japan.
  • Moriya K; Center for Information Biology, National Institute of Genetics, Shizuoka, Japan.
  • Suzuki K; Laboratory of Morphology and Image Analysis, and.
  • Miida T; Department of Clinical Laboratory Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
  • Kim YM; Research Institute for Diseases of Old Age, Juntendo University Graduate School of Medicine, Tokyo, Japan.
  • Vellano CP; Department of Clinical Laboratory Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
  • Andreeff M; Pediatrics and Pathology, Keck School of Medicine, University of Southern California, Los Angeles, CA.
  • Marszalek JR; TRACTION, Therapeutics Discovery Division, The University of Texas MD Anderson Cancer Center, Houston, TX; and.
  • Tabe Y; Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Konopleva M; TRACTION, Therapeutics Discovery Division, The University of Texas MD Anderson Cancer Center, Houston, TX; and.
Blood Adv ; 5(20): 4233-4255, 2021 10 26.
Article em En | MEDLINE | ID: mdl-34507353
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fosforilação Oxidativa / Leucemia Mieloide Aguda Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fosforilação Oxidativa / Leucemia Mieloide Aguda Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article